Document is current
Any future updates will be listed below
-
Authors
Venn-Watson, Stephanie
Reiner, John
Jensen, Eric D.
-
Funding
Funding for this research was provided by:
Office of Naval Research (ONR SBIR #N00014-21-9-0002, ONR SBIR #N00014-21-9-0002)
Cooperative Research and Development Agreement with the Naval Warfare Information Center Pacific (NCRADA-NIWCPacific-17-261, NCRADA-NIWCPacific-17-261, NCRADA-NIWCPacific-17-261)
- License Information
-
More Information
Article History
Received: 19 March 2022
Accepted: 8 August 2022
First Online: 23 August 2022
Competing interests
: S.V. is a co-founder of and employed by Epitracker, Inc and Seraphina Therapeutics, Inc, which hold exclusive licensing rights from the U.S. Navy to commercialize odd-chain saturated fatty acids as human and animal health products. J.R. is employed by Epitracker.
